Scarica l'app Stockscreener
1.56
2.50%
-0.04
Dopo l'orario di chiusura:
1.57
0.01
+0.64%
Precedente Chiudi:
$1.60
Aprire:
$1.64
Volume 24 ore:
14,676
Relative Volume:
0.41
Capitalizzazione di mercato:
$25.29M
Reddito:
-
Utile/perdita netta:
$-13.59M
Rapporto P/E:
-1.4444
EPS:
-1.08
Flusso di cassa netto:
$-19.79M
1 W Prestazione:
-5.45%
1M Prestazione:
-8.77%
6M Prestazione:
-55.93%
1 anno Prestazione:
-63.29%
Intervallo 1D:
$1.5472
$1.85
Intervallo di 1 settimana:
$1.42
$1.85
Portata 52W:
$1.42
$5.97
Calcimedica Inc Stock (CALC) Company Profile
Nome
Calcimedica Inc
Settore
Industria
Telefono
858-952-5500
Indirizzo
505 COAST BOULEVARD SOUTH, LA JOLLA
Confronta CALC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
1.56 | 25.29M | 0 | -13.59M | -19.79M | -1.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.16 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
534.91 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.06 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
542.47 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.16 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Calcimedica Inc Borsa (CALC) Ultime notizie
CalciMedica Insiders Added US$1.05m Of Stock To Their Holdings - Yahoo Finance
CalciMedica's Breakthrough AKI Treatment Takes Center Stage at Prestigious Vicenza Nephrology Conference - Stock Titan
Millennium Management LLC Acquires 16,824 Shares of CalciMedica, Inc. (NASDAQ:CALC) - Defense World
calcimedica appoints baker tilly as new accounting firm after merger By Investing.com - Investing.com South Africa
calcimedica appoints baker tilly as new accounting firm after merger - Investing.com
HC Wainwright Reiterates “Buy” Rating for CalciMedica (NASDAQ:CALC) - Defense World
CalciMedica (CALC) Receives Reiteration of Buy Rating with $16 P - GuruFocus
CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates - Citizen Tribune
CalciMedica (CALC) Expected to Announce Quarterly Earnings on Monday - Defense World
CalciMedica Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
Renaissance Technologies LLC Purchases New Stake in CalciMedica, Inc. (NASDAQ:CALC) - Defense World
Geode Capital Management LLC Boosts Stock Holdings in CalciMedica, Inc. (NASDAQ:CALC) - Defense World
Bristol-Myers Squibb (NYSE:BMY) vs. CalciMedica (NASDAQ:CALC) Critical Review - Defense World
CalciMedica (NASDAQ:CALC) Shares Up 0.7% – Here’s Why - Defense World
CalciMedica's Breakthrough Research Takes Center Stage at Two Elite Medical Conferences - Stock Titan
CalciMedica Announces Presentations at Upcoming Medical Meetings - PR Newswire
Analysts Offer Predictions for CalciMedica Q4 Earnings - Defense World
CalciMedica Inc. (CALC) Moves to Buy: Rationale Behind the Upgrade - Yahoo Finance
Corient Private Wealth LLC Buys New Shares in CalciMedica, Inc. (NASDAQ:CALC) - Defense World
CalciMedica (NASDAQ:CALC) Receives “Buy” Rating from HC Wainwright - Defense World
Corient Private Wealth LLC Acquires Shares of 38,000 CalciMedica, Inc. (NASDAQ:CALC) - The AM Reporter
Graybug Vision stock hits 52-week low at $1.81 - Investing.com India
Graybug Vision stock hits 52-week low at $1.81 By Investing.com - Investing.com South Africa
H.C. Wainwright maintains $16 target on CalciMedica stock - Investing.com Australia
CalciMedica’s Strong Financial Position and Promising Clinical Pipeline Justify Buy Rating - TipRanks
CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference - PR Newswire
CalciMedica says cash sufficient to fund operating plan into mid-2026 - TipRanks
CALCIMEDICA Earnings Results: $CALC Reports Quarterly Earnings - Nasdaq
CalciMedica Inc reports results for the quarter ended December 31Earnings Summary - TradingView
CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates - Citizen Tribune
Calcimedica Reports 2024 Financial Results And Provides Clinical & Corporate Updates - MarketScreener
CalciMedica (CALC) to Release Earnings on Thursday - The AM Reporter
CalciMedica Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView
Atria Investments Inc Buys 7,509 Shares of CalciMedica, Inc. (NASDAQ:CALC) - Defense World
CalciMedica (CALC) Expected to Announce Quarterly Earnings on Thursday - Defense World
Graybug Vision stock hits 52-week low at $1.83 amid challenges - Investing.com
Rani Therapeutics (NASDAQ:RANI) versus CalciMedica (NASDAQ:CALC) Financial Contrast - Defense World
Promising Phase 2 Results and Market Potential Drive Buy Rating for CalciMedica’s Auxora - TipRanks
Short Interest in CalciMedica, Inc. (NASDAQ:CALC) Increases By 35.0% - Defense World
Latham & Watkins Advises CalciMedica in Secured Growth Financing - Latham & Watkins LLP
CalciMedica secures $32.5 million credit facility By Investing.com - Investing.com Canada
CalciMedica secures credit facility for up to $32.5M - MSN
CalciMedica Secures Credit Facility For Up To $32.5 Million -March 05, 2025 at 07:44 am EST - Marketscreener.com
CalciMedica secures $32.5 million credit facility - Investing.com India
CalciMedica Secures Credit Facility for Up to $32.5 Million - Finansavisen
CalciMedica (NASDAQ:CALC) Given “Buy” Rating at HC Wainwright - Defense World
Graybug Vision stock hits 52-week low at $1.95 amid challenges - Investing.com
CalciMedica reports reduced mortality in AKI trial with Auxora - Investing.com
CalciMedica Highlights Auxora’s Potential in COVID-19 Treatment - TipRanks
CalciMedica reports reduced mortality in AKI trial with Auxora By Investing.com - Investing.com South Africa
CalciMedica’s Auxora shows mortality reduction in COVID-19 pneumonia trial - TipRanks
Calcimedica Inc Azioni (CALC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Calcimedica Inc Azioni (CALC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bardin Stephen | Chief Financial Officer |
Jun 26 '25 |
Buy |
1.50 |
2,000 |
3,005 |
3,000 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Jun 11 '25 |
Buy |
1.85 |
5,000 |
9,250 |
28,323 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Jun 06 '25 |
Buy |
1.77 |
5,000 |
8,875 |
23,323 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Jun 05 '25 |
Buy |
1.70 |
5,100 |
8,670 |
18,323 |
| Bardin Stephen | Chief Financial Officer |
May 30 '25 |
Buy |
1.69 |
1,000 |
1,690 |
41,000 |
| MIDDLETON FRED A | Director |
Dec 06 '24 |
Buy |
2.65 |
4,800 |
12,720 |
36,514 |
| Sanderling Venture Partners VI | 10% Owner |
Nov 01 '24 |
Buy |
3.75 |
86,867 |
325,751 |
814,300 |
| Sanderling Venture Partners VI | 10% Owner |
Nov 01 '24 |
Buy |
3.75 |
877 |
3,289 |
22,479 |
| MIDDLETON FRED A | Director |
Nov 01 '24 |
Buy |
3.75 |
87,744 |
329,040 |
814,300 |
| MIDDLETON FRED A | Director |
Nov 01 '24 |
Buy |
3.75 |
20,000 |
75,000 |
31,714 |
0.39%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):